QuiaPEG Pharmaceuticals Holding AB logo

QUIA BTU - QuiaPEG Pharmaceuticals Holding AB News Story

SEK11.4 0.4  3.6%

Last Trade - 07/08/20

Sector
Industrials
Size
Micro Cap
Market Cap £12.7m
Enterprise Value £13.7m
Revenue £n/a
Position in Universe 1408th / 1782

BRIEF-QuiapPEG Pharmaceuticals Holding Presents Positive Preclinical Results For QPG-1029

Tue 11th February, 2020 10:31am
Feb 11 (Reuters) - QuiaPEG Pharmaceuticals Holding AB
 QUIA.TE :
    * PRESENTS POSITIVE PRECLINICAL RESULTS FOR QPG-1029
    * THE RESULTS MEAN THAT QUIAPEG CONTINUES THE DEVELOPMENT
PROGRAM
FOR QPG-1029
    * RESULTS FROM PRECLINICAL STUDY SHOW FOR THE FIRST TIME
THAT
QPG-1029 CAN BE ABSORBED IN BLOOD CIRCULATION AFTER INJECTION
    * AFTER EVALUATION OF TREATMENT EFFECT IN PROOF-OF-CONCEPT
STUDY
CO IS TO CONDUCT PHARMACOKINETIC STUDIES WITH REPEATED DOSING,
COMPLETE WITH TOXICOLOGY AND SAFETY STUDIES TO BE PERFORMED
BEFORE CLINICAL PROGRAM WILL START
    * RESULTS FROM PRECLINICAL STUDY SHOW THAT THE DRUG
LIRAGLUTID IS
RELEASED IN BLOOD PLASMA AFTER BOTH INTRAVENOUS AND SUBCUTANEOUS
ADMINISTRATION

Source text for Eikon:  ID:nWkr1p9Wv7 
Further company coverage:  QUIA.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.